408 related articles for article (PubMed ID: 24310298)
1. Pulmonary function and autoantibodies in a long-term follow-up of juvenile dermatomyositis patients.
Mathiesen PR; Buchvald F; Nielsen KG; Herlin T; Friis T; Nielsen S
Rheumatology (Oxford); 2014 Apr; 53(4):644-9. PubMed ID: 24310298
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study.
Mathiesen P; Hegaard H; Herlin T; Zak M; Pedersen FK; Nielsen S
Scand J Rheumatol; 2012 Feb; 41(1):50-8. PubMed ID: 22044089
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary outcome in juvenile dermatomyositis: a case-control study.
Sanner H; Aaløkken TM; Gran JT; Sjaastad I; Johansen B; Flatø B
Ann Rheum Dis; 2011 Jan; 70(1):86-91. PubMed ID: 20805295
[TBL] [Abstract][Full Text] [Related]
4. Novel associations between cytokines and pulmonary involvement in juvenile dermatomyositis - a cross-sectional study of long-term disease.
Marstein H; Schwartz T; Aaløkken TM; Lund MB; Flatø B; Sjaastad I; Sanner H
Rheumatology (Oxford); 2020 Aug; 59(8):1862-1870. PubMed ID: 31740970
[TBL] [Abstract][Full Text] [Related]
5. Clinical associations of autoantibodies to a p155/140 kDa doublet protein in juvenile dermatomyositis.
Gunawardena H; Wedderburn LR; North J; Betteridge Z; Dunphy J; Chinoy H; Davidson JE; Cooper RG; McHugh NJ;
Rheumatology (Oxford); 2008 Mar; 47(3):324-8. PubMed ID: 18238791
[TBL] [Abstract][Full Text] [Related]
6. Cumulative organ damage and prognostic factors in juvenile dermatomyositis: a cross-sectional study median 16.8 years after symptom onset.
Sanner H; Gran JT; Sjaastad I; Flatø B
Rheumatology (Oxford); 2009 Dec; 48(12):1541-7. PubMed ID: 19776224
[TBL] [Abstract][Full Text] [Related]
7. Disease activity and prognostic factors in juvenile dermatomyositis: a long-term follow-up study applying the Paediatric Rheumatology International Trials Organization criteria for inactive disease and the myositis disease activity assessment tool.
Sanner H; Sjaastad I; Flatø B
Rheumatology (Oxford); 2014 Sep; 53(9):1578-85. PubMed ID: 24692575
[TBL] [Abstract][Full Text] [Related]
8. The lung is involved in juvenile dermatomyositis.
Pouessel G; Deschildre A; Le Bourgeois M; Cuisset JM; Catteau B; Karila C; Nève V; Thumerelle C; Quartier P; Tillie-Leblond I
Pediatr Pulmonol; 2013 Oct; 48(10):1016-25. PubMed ID: 23281200
[TBL] [Abstract][Full Text] [Related]
9. Anti-Ro52 autoantibodies are associated with interstitial lung disease and more severe disease in patients with juvenile myositis.
Sabbagh S; Pinal-Fernandez I; Kishi T; Targoff IN; Miller FW; Rider LG; Mammen AL;
Ann Rheum Dis; 2019 Jul; 78(7):988-995. PubMed ID: 31018961
[TBL] [Abstract][Full Text] [Related]
10. In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity.
Schwartz T; Sanner H; Gjesdal O; Flatø B; Sjaastad I
Ann Rheum Dis; 2014 Oct; 73(10):1805-10. PubMed ID: 23881732
[TBL] [Abstract][Full Text] [Related]
11. The arthritis of inflammatory childhood myositis syndromes.
Tse S; Lubelsky S; Gordon M; Al Mayouf SM; Babyn PS; Laxer RM; Silverman ED; Schneider R; Feldman BM
J Rheumatol; 2001 Jan; 28(1):192-7. PubMed ID: 11196524
[TBL] [Abstract][Full Text] [Related]
12. Oropharyngeal dysphagia in juvenile dermatomyositis (JDM): an evaluation of videofluoroscopy swallow study (VFSS) changes in relation to clinical symptoms and objective muscle scores.
McCann LJ; Garay SM; Ryan MM; Harris R; Riley P; Pilkington CA
Rheumatology (Oxford); 2007 Aug; 46(8):1363-6. PubMed ID: 17569746
[TBL] [Abstract][Full Text] [Related]
13. Decreased body mass index and restrictive lung disease in congenital thoracic scoliosis.
Bowen RE; Scaduto AA; Banuelos S
J Pediatr Orthop; 2008 Sep; 28(6):665-8. PubMed ID: 18724205
[TBL] [Abstract][Full Text] [Related]
14. Submaximal Exercise Capacity in Juvenile Dermatomyositis after Longterm Disease: The Contribution of Muscle, Lung, and Heart Involvement.
Berntsen KS; Tollisen A; Schwartz T; Kirkhus E; Aaløkken TM; Lund MB; Flatø B; Sjaastad I; Sanner H
J Rheumatol; 2017 Jun; 44(6):827-834. PubMed ID: 28365577
[TBL] [Abstract][Full Text] [Related]
15. Aerobic fitness after JDM--a long-term follow-up study.
Mathiesen PR; Ørngreen MC; Vissing J; Andersen LB; Herlin T; Nielsen S
Rheumatology (Oxford); 2013 Feb; 52(2):287-95. PubMed ID: 23001614
[TBL] [Abstract][Full Text] [Related]
16. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.
Wedderburn LR; McHugh NJ; Chinoy H; Cooper RG; Salway F; Ollier WE; McCann LJ; Varsani H; Dunphy J; North J; Davidson JE;
Rheumatology (Oxford); 2007 Dec; 46(12):1786-91. PubMed ID: 18003662
[TBL] [Abstract][Full Text] [Related]
17. Associations between cardiac and pulmonary involvement in patients with juvenile dermatomyositis-a cross-sectional study.
Witczak BN; Schwartz T; Barth Z; Taraldsrud E; Lund MB; Aaløkken TM; Flatø B; Sjaastad I; Sanner H
Rheumatol Int; 2022 Jul; 42(7):1213-1220. PubMed ID: 34984516
[TBL] [Abstract][Full Text] [Related]
18. Anti-melanoma differentiation-associated gene 5 antibody is a diagnostic and predictive marker for interstitial lung diseases associated with juvenile dermatomyositis.
Kobayashi I; Okura Y; Yamada M; Kawamura N; Kuwana M; Ariga T
J Pediatr; 2011 Apr; 158(4):675-7. PubMed ID: 21232756
[TBL] [Abstract][Full Text] [Related]
19. Recent research on myositis-specific autoantibodies in juvenile dermatomyositis.
He L
Zhongguo Dang Dai Er Ke Za Zhi; 2021 Oct; 23(10):1064-1068. PubMed ID: 34719424
[TBL] [Abstract][Full Text] [Related]
20. [The analysis of clinical phenotypes and autoantibodies in juvenile dermatomyositis].
Li DM; Wang L; Liu MY; Xu L; Tang XM
Zhonghua Er Ke Za Zhi; 2020 Dec; 58(12):966-972. PubMed ID: 33256317
[No Abstract] [Full Text] [Related]
[Next] [New Search]
